Concepedia

Daniel J. Anderson

DJ

Statistics

Publications

31

Citations

6.9K

H-Index

23

Active since

1991

Affiliations

Salk Institute for Biological Studies(Current)

Aptose Biosciences (United States)

University of California, Berkeley

The University of Melbourne

Walter and Eliza Hall Institute of Medical Research

Daniel J. Anderson is an author at Salk Institute for Biological Studies specializing in molecular biology, life sciences, and cell biology.

Publications per year

1991–2025

31

Publications

31

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

Georgia Hatzivassiliou, Kyung Song, Ivana Yen et al. · Nature · 2010 · 1.6K citations

Medicine, Cancer Biology, Oncology +15

Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7

Ingrid E. Wertz, Saritha Kusam, Cynthia Lam et al. · Nature · 2011 · 810 citations

Medicine, Molecular Biology, Oncology +7

Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity

Till Maurer, Lindsay S. Garrenton, Angela Oh et al. · Proceedings of the National Academy of Sciences · 2012 · 630 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)

H Zhang, J Chen, Sajid Khan Tahir et al. · Cell Death and Disease · 2015 · 429 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis

Daniel J. Anderson, Ronan Le Moigne, Stevan Djakovic et al. · Cancer Cell · 2015 · 401 citations · Full text

Life Sciences, Molecular Biology, Oncology +8

1–5 of 31